nodes	percent_of_prediction	percent_of_DWPC	metapath
Saquinavir—CYP11A1—Cholecalciferol—psoriasis	0.071	0.0968	CbGbCtD
Saquinavir—CYP11A1—Dexamethasone—psoriasis	0.0307	0.0419	CbGbCtD
Saquinavir—ALB—Acitretin—psoriasis	0.0247	0.0337	CbGbCtD
Saquinavir—CYP2C8—Tazarotene—psoriasis	0.0242	0.033	CbGbCtD
Saquinavir—CYP3A5—Beclomethasone—psoriasis	0.0234	0.0319	CbGbCtD
Saquinavir—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0212	0.0288	CbGbCtD
Saquinavir—ABCC1—Cyclosporine—psoriasis	0.019	0.0259	CbGbCtD
Saquinavir—SLCO1A2—Prednisolone—psoriasis	0.019	0.0259	CbGbCtD
Saquinavir—ABCC2—Mycophenolate mofetil—psoriasis	0.0186	0.0253	CbGbCtD
Saquinavir—SLCO1A2—Hydrocortisone—psoriasis	0.018	0.0245	CbGbCtD
Saquinavir—SLCO1A2—Prednisone—psoriasis	0.0179	0.0244	CbGbCtD
Saquinavir—SLCO1A2—Cyclosporine—psoriasis	0.017	0.0232	CbGbCtD
Saquinavir—ABCG2—Mycophenolate mofetil—psoriasis	0.0168	0.0229	CbGbCtD
Saquinavir—SLCO1B1—Cyclosporine—psoriasis	0.016	0.0219	CbGbCtD
Saquinavir—ABCC2—Cyclosporine—psoriasis	0.0141	0.0192	CbGbCtD
Saquinavir—ABCG2—Hydrocortisone—psoriasis	0.0135	0.0184	CbGbCtD
Saquinavir—ABCG2—Cyclosporine—psoriasis	0.0127	0.0174	CbGbCtD
Saquinavir—ALB—Mycophenolate mofetil—psoriasis	0.0116	0.0158	CbGbCtD
Saquinavir—SLCO1A2—Dexamethasone—psoriasis	0.0112	0.0153	CbGbCtD
Saquinavir—CYP2D6—Hydroxyurea—psoriasis	0.0109	0.0148	CbGbCtD
Saquinavir—CYP2C8—Cholecalciferol—psoriasis	0.0103	0.0141	CbGbCtD
Saquinavir—ABCC1—Methotrexate—psoriasis	0.0101	0.0137	CbGbCtD
Saquinavir—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.00996	0.0136	CbGbCtD
Saquinavir—CYP3A7—Hydrocortisone—psoriasis	0.00996	0.0136	CbGbCtD
Saquinavir—CYP3A7—Cyclosporine—psoriasis	0.00941	0.0128	CbGbCtD
Saquinavir—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.00941	0.0128	CbGbCtD
Saquinavir—CYP3A5—Mycophenolate mofetil—psoriasis	0.00931	0.0127	CbGbCtD
Saquinavir—ABCC2—Dexamethasone—psoriasis	0.00928	0.0126	CbGbCtD
Saquinavir—ALB—Prednisone—psoriasis	0.00926	0.0126	CbGbCtD
Saquinavir—SLCO1A2—Methotrexate—psoriasis	0.00899	0.0123	CbGbCtD
Saquinavir—CYP2C8—Mycophenolate mofetil—psoriasis	0.00895	0.0122	CbGbCtD
Saquinavir—CYP2C19—Cholecalciferol—psoriasis	0.00866	0.0118	CbGbCtD
Saquinavir—SLCO1B1—Methotrexate—psoriasis	0.00849	0.0116	CbGbCtD
Saquinavir—ABCG2—Dexamethasone—psoriasis	0.00839	0.0114	CbGbCtD
Saquinavir—CYP3A4—Calcitriol—psoriasis	0.00813	0.0111	CbGbCtD
Saquinavir—CYP3A5—Hydrocortisone—psoriasis	0.00747	0.0102	CbGbCtD
Saquinavir—Remikiren—REN—psoriasis	0.00746	0.94	CrCbGaD
Saquinavir—ABCC2—Methotrexate—psoriasis	0.00746	0.0102	CbGbCtD
Saquinavir—CYP2C9—Cholecalciferol—psoriasis	0.0072	0.00982	CbGbCtD
Saquinavir—CYP2C8—Hydrocortisone—psoriasis	0.00719	0.00979	CbGbCtD
Saquinavir—CYP3A5—Cyclosporine—psoriasis	0.00706	0.00962	CbGbCtD
Saquinavir—CYP2C8—Cyclosporine—psoriasis	0.00679	0.00925	CbGbCtD
Saquinavir—ABCG2—Methotrexate—psoriasis	0.00674	0.00919	CbGbCtD
Saquinavir—CYP2D6—Cholecalciferol—psoriasis	0.00659	0.00898	CbGbCtD
Saquinavir—CYP3A4—Methoxsalen—psoriasis	0.00632	0.00862	CbGbCtD
Saquinavir—CYP3A7—Dexamethasone—psoriasis	0.0062	0.00844	CbGbCtD
Saquinavir—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0062	0.00844	CbGbCtD
Saquinavir—ABCB1—Mycophenolate mofetil—psoriasis	0.00606	0.00826	CbGbCtD
Saquinavir—CYP2C19—Prednisone—psoriasis	0.00601	0.00819	CbGbCtD
Saquinavir—CYP2C19—Cyclosporine—psoriasis	0.00569	0.00776	CbGbCtD
Saquinavir—ABCB1—Betamethasone—psoriasis	0.0052	0.00709	CbGbCtD
Saquinavir—ABCB1—Prednisolone—psoriasis	0.00513	0.00699	CbGbCtD
Saquinavir—ABCB1—Hydrocortisone—psoriasis	0.00486	0.00663	CbGbCtD
Saquinavir—ABCB1—Prednisone—psoriasis	0.00485	0.0066	CbGbCtD
Saquinavir—CYP2C9—Cyclosporine—psoriasis	0.00473	0.00645	CbGbCtD
Saquinavir—CYP3A5—Dexamethasone—psoriasis	0.00465	0.00633	CbGbCtD
Saquinavir—ALB—Methotrexate—psoriasis	0.00465	0.00633	CbGbCtD
Saquinavir—ABCB1—Cyclosporine—psoriasis	0.00459	0.00626	CbGbCtD
Saquinavir—CYP2C8—Dexamethasone—psoriasis	0.00447	0.00609	CbGbCtD
Saquinavir—CYP2D6—Cyclosporine—psoriasis	0.00433	0.0059	CbGbCtD
Saquinavir—CYP3A4—Cholecalciferol—psoriasis	0.00419	0.00571	CbGbCtD
Saquinavir—CYP2C19—Dexamethasone—psoriasis	0.00375	0.00511	CbGbCtD
Saquinavir—CYP3A4—Mycophenolate mofetil—psoriasis	0.00363	0.00495	CbGbCtD
Saquinavir—CYP3A4—Triamcinolone—psoriasis	0.00363	0.00495	CbGbCtD
Saquinavir—CYP2C9—Dexamethasone—psoriasis	0.00312	0.00425	CbGbCtD
Saquinavir—CYP3A4—Betamethasone—psoriasis	0.00312	0.00425	CbGbCtD
Saquinavir—CYP3A4—Prednisolone—psoriasis	0.00307	0.00419	CbGbCtD
Saquinavir—ABCB1—Dexamethasone—psoriasis	0.00302	0.00412	CbGbCtD
Saquinavir—CYP3A4—Hydrocortisone—psoriasis	0.00291	0.00397	CbGbCtD
Saquinavir—CYP3A4—Prednisone—psoriasis	0.0029	0.00396	CbGbCtD
Saquinavir—CYP2D6—Dexamethasone—psoriasis	0.00285	0.00388	CbGbCtD
Saquinavir—CYP3A4—Cyclosporine—psoriasis	0.00275	0.00375	CbGbCtD
Saquinavir—ABCB1—Methotrexate—psoriasis	0.00243	0.00331	CbGbCtD
Saquinavir—CYP3A4—Dexamethasone—psoriasis	0.00181	0.00247	CbGbCtD
Saquinavir—Mitiglinide—PPARG—psoriasis	0.000474	0.0597	CrCbGaD
Saquinavir—ABCG2—HIF-1-alpha transcription factor network—CP—psoriasis	0.000189	0.00712	CbGpPWpGaD
Saquinavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000179	0.00674	CbGpPWpGaD
Saquinavir—ALB—HDL-mediated lipid transport—APOE—psoriasis	0.000174	0.00656	CbGpPWpGaD
Saquinavir—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000172	0.00649	CbGpPWpGaD
Saquinavir—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.00017	0.00641	CbGpPWpGaD
Saquinavir—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.000168	0.00632	CbGpPWpGaD
Saquinavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000164	0.0062	CbGpPWpGaD
Saquinavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000163	0.00615	CbGpPWpGaD
Saquinavir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000147	0.00553	CbGpPWpGaD
Saquinavir—ABCC1—S1P1 pathway—VEGFA—psoriasis	0.000143	0.00539	CbGpPWpGaD
Saquinavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000133	0.005	CbGpPWpGaD
Saquinavir—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000131	0.00494	CbGpPWpGaD
Saquinavir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000128	0.00483	CbGpPWpGaD
Saquinavir—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000123	0.00463	CbGpPWpGaD
Saquinavir—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000121	0.00457	CbGpPWpGaD
Saquinavir—ABCC2—NRF2 pathway—TGFA—psoriasis	0.00011	0.00414	CbGpPWpGaD
Saquinavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000107	0.00406	CbGpPWpGaD
Saquinavir—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000106	0.00401	CbGpPWpGaD
Saquinavir—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000106	0.004	CbGpPWpGaD
Saquinavir—CYP11A1—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.000106	0.004	CbGpPWpGaD
Saquinavir—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000105	0.00396	CbGpPWpGaD
Saquinavir—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000102	0.00385	CbGpPWpGaD
Saquinavir—ALB—Lipoprotein metabolism—APOE—psoriasis	9.98e-05	0.00377	CbGpPWpGaD
Saquinavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.88e-05	0.00373	CbGpPWpGaD
Saquinavir—CYP2C19—Biological oxidations—CYP2S1—psoriasis	9.49e-05	0.00358	CbGpPWpGaD
Saquinavir—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	9.36e-05	0.00353	CbGpPWpGaD
Saquinavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.23e-05	0.00348	CbGpPWpGaD
Saquinavir—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	9.21e-05	0.00347	CbGpPWpGaD
Saquinavir—CYP2D6—Biological oxidations—CYP2S1—psoriasis	8.73e-05	0.00329	CbGpPWpGaD
Saquinavir—CYP2C9—Biological oxidations—CYP2S1—psoriasis	8.66e-05	0.00327	CbGpPWpGaD
Saquinavir—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	8.61e-05	0.00325	CbGpPWpGaD
Saquinavir—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	8.61e-05	0.00325	CbGpPWpGaD
Saquinavir—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	8.54e-05	0.00322	CbGpPWpGaD
Saquinavir—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	8.47e-05	0.00319	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—SERPINB8—psoriasis	8.14e-05	0.00307	CbGpPWpGaD
Saquinavir—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	8.02e-05	0.00303	CbGpPWpGaD
Saquinavir—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	7.96e-05	0.003	CbGpPWpGaD
Saquinavir—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	7.9e-05	0.00298	CbGpPWpGaD
Saquinavir—ABCB1—Allograft Rejection—HLA-C—psoriasis	7.88e-05	0.00297	CbGpPWpGaD
Saquinavir—ABCB1—Allograft Rejection—IL13—psoriasis	7.83e-05	0.00295	CbGpPWpGaD
Saquinavir—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	7.77e-05	0.00293	CbGpPWpGaD
Saquinavir—CYP11A1—Corticotropin-releasing hormone—CXCL8—psoriasis	7.56e-05	0.00285	CbGpPWpGaD
Saquinavir—ABCB1—Allograft Rejection—IL17A—psoriasis	7.21e-05	0.00272	CbGpPWpGaD
Saquinavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.89e-05	0.0026	CbGpPWpGaD
Saquinavir—ALB—Folate Metabolism—CAT—psoriasis	6.84e-05	0.00258	CbGpPWpGaD
Saquinavir—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	6.81e-05	0.00257	CbGpPWpGaD
Saquinavir—CYP11A1—Corticotropin-releasing hormone—NFKB1—psoriasis	6.76e-05	0.00255	CbGpPWpGaD
Saquinavir—ABCB1—Allograft Rejection—IL12B—psoriasis	6.7e-05	0.00253	CbGpPWpGaD
Saquinavir—ALB—Vitamin B12 Metabolism—CRP—psoriasis	6.67e-05	0.00252	CbGpPWpGaD
Saquinavir—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	6.63e-05	0.0025	CbGpPWpGaD
Saquinavir—ABCB1—Allograft Rejection—HLA-E—psoriasis	6.54e-05	0.00247	CbGpPWpGaD
Saquinavir—ALB—Vitamin B12 Metabolism—APOE—psoriasis	6.53e-05	0.00246	CbGpPWpGaD
Saquinavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.44e-05	0.00243	CbGpPWpGaD
Saquinavir—ALB—Folate Metabolism—IL4—psoriasis	6.28e-05	0.00237	CbGpPWpGaD
Saquinavir—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	6.13e-05	0.00231	CbGpPWpGaD
Saquinavir—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	6.11e-05	0.00231	CbGpPWpGaD
Saquinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.09e-05	0.0023	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—NDUFA5—psoriasis	5.94e-05	0.00224	CbGpPWpGaD
Saquinavir—SLC22A1—SLC-mediated transmembrane transport—CP—psoriasis	5.82e-05	0.00219	CbGpPWpGaD
Saquinavir—CYP3A4—Biological oxidations—CYP2S1—psoriasis	5.71e-05	0.00215	CbGpPWpGaD
Saquinavir—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	5.63e-05	0.00212	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.54e-05	0.00209	CbGpPWpGaD
Saquinavir—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	5.47e-05	0.00207	CbGpPWpGaD
Saquinavir—ALB—Selenium Micronutrient Network—CAT—psoriasis	5.43e-05	0.00205	CbGpPWpGaD
Saquinavir—ALB—Folate Metabolism—CRP—psoriasis	5.43e-05	0.00205	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	5.41e-05	0.00204	CbGpPWpGaD
Saquinavir—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	5.32e-05	0.00201	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—CYP2S1—psoriasis	5.05e-05	0.00191	CbGpPWpGaD
Saquinavir—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	5.03e-05	0.0019	CbGpPWpGaD
Saquinavir—ALB—Folate Metabolism—ICAM1—psoriasis	4.99e-05	0.00188	CbGpPWpGaD
Saquinavir—CYP3A4—Tryptophan metabolism—CAT—psoriasis	4.93e-05	0.00186	CbGpPWpGaD
Saquinavir—ABCB1—Allograft Rejection—IL10—psoriasis	4.9e-05	0.00185	CbGpPWpGaD
Saquinavir—ABCB1—Allograft Rejection—IL4—psoriasis	4.76e-05	0.0018	CbGpPWpGaD
Saquinavir—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	4.67e-05	0.00176	CbGpPWpGaD
Saquinavir—ABCB1—Allograft Rejection—HLA-B—psoriasis	4.66e-05	0.00176	CbGpPWpGaD
Saquinavir—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	4.65e-05	0.00176	CbGpPWpGaD
Saquinavir—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	4.65e-05	0.00175	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—NDUFA5—psoriasis	4.35e-05	0.00164	CbGpPWpGaD
Saquinavir—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	4.34e-05	0.00164	CbGpPWpGaD
Saquinavir—ABCB1—Allograft Rejection—HLA-A—psoriasis	4.32e-05	0.00163	CbGpPWpGaD
Saquinavir—ALB—Selenium Micronutrient Network—CRP—psoriasis	4.31e-05	0.00163	CbGpPWpGaD
Saquinavir—Body temperature increased—Cyclosporine—psoriasis	4.3e-05	0.000186	CcSEcCtD
Saquinavir—Anxiety—Dexamethasone—psoriasis	4.3e-05	0.000185	CcSEcCtD
Saquinavir—Anxiety—Betamethasone—psoriasis	4.3e-05	0.000185	CcSEcCtD
Saquinavir—Vomiting—Mycophenolic acid—psoriasis	4.28e-05	0.000185	CcSEcCtD
Saquinavir—Discomfort—Betamethasone—psoriasis	4.26e-05	0.000184	CcSEcCtD
Saquinavir—Discomfort—Dexamethasone—psoriasis	4.26e-05	0.000184	CcSEcCtD
Saquinavir—Dyspepsia—Hydrocortisone—psoriasis	4.26e-05	0.000184	CcSEcCtD
Saquinavir—Haemoglobin—Methotrexate—psoriasis	4.26e-05	0.000184	CcSEcCtD
Saquinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.25e-05	0.0016	CbGpPWpGaD
Saquinavir—Rash—Mycophenolic acid—psoriasis	4.24e-05	0.000183	CcSEcCtD
Saquinavir—Dermatitis—Mycophenolic acid—psoriasis	4.24e-05	0.000183	CcSEcCtD
Saquinavir—Pain—Prednisolone—psoriasis	4.24e-05	0.000183	CcSEcCtD
Saquinavir—Hepatitis—Methotrexate—psoriasis	4.24e-05	0.000183	CcSEcCtD
Saquinavir—Haemorrhage—Methotrexate—psoriasis	4.24e-05	0.000183	CcSEcCtD
Saquinavir—Urticaria—Mycophenolate mofetil—psoriasis	4.22e-05	0.000182	CcSEcCtD
Saquinavir—Headache—Mycophenolic acid—psoriasis	4.22e-05	0.000182	CcSEcCtD
Saquinavir—Decreased appetite—Hydrocortisone—psoriasis	4.21e-05	0.000181	CcSEcCtD
Saquinavir—Pharyngitis—Methotrexate—psoriasis	4.2e-05	0.000181	CcSEcCtD
Saquinavir—Abdominal pain—Mycophenolate mofetil—psoriasis	4.2e-05	0.000181	CcSEcCtD
Saquinavir—Body temperature increased—Mycophenolate mofetil—psoriasis	4.2e-05	0.000181	CcSEcCtD
Saquinavir—Urinary tract disorder—Methotrexate—psoriasis	4.18e-05	0.00018	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Hydrocortisone—psoriasis	4.18e-05	0.00018	CcSEcCtD
Saquinavir—Fatigue—Hydrocortisone—psoriasis	4.17e-05	0.00018	CcSEcCtD
Saquinavir—Urethral disorder—Methotrexate—psoriasis	4.15e-05	0.000179	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Triamcinolone—psoriasis	4.15e-05	0.000179	CcSEcCtD
Saquinavir—Pain—Hydrocortisone—psoriasis	4.14e-05	0.000178	CcSEcCtD
Saquinavir—Oedema—Betamethasone—psoriasis	4.13e-05	0.000178	CcSEcCtD
Saquinavir—Oedema—Dexamethasone—psoriasis	4.13e-05	0.000178	CcSEcCtD
Saquinavir—Insomnia—Triamcinolone—psoriasis	4.12e-05	0.000178	CcSEcCtD
Saquinavir—Infection—Dexamethasone—psoriasis	4.11e-05	0.000177	CcSEcCtD
Saquinavir—Infection—Betamethasone—psoriasis	4.11e-05	0.000177	CcSEcCtD
Saquinavir—Ill-defined disorder—Prednisone—psoriasis	4.09e-05	0.000177	CcSEcCtD
Saquinavir—Paraesthesia—Triamcinolone—psoriasis	4.09e-05	0.000176	CcSEcCtD
Saquinavir—Feeling abnormal—Prednisolone—psoriasis	4.08e-05	0.000176	CcSEcCtD
Saquinavir—Visual impairment—Methotrexate—psoriasis	4.08e-05	0.000176	CcSEcCtD
Saquinavir—Anaemia—Prednisone—psoriasis	4.08e-05	0.000176	CcSEcCtD
Saquinavir—Shock—Dexamethasone—psoriasis	4.07e-05	0.000175	CcSEcCtD
Saquinavir—Shock—Betamethasone—psoriasis	4.07e-05	0.000175	CcSEcCtD
Saquinavir—Dyspnoea—Triamcinolone—psoriasis	4.06e-05	0.000175	CcSEcCtD
Saquinavir—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.06e-05	0.00153	CbGpPWpGaD
Saquinavir—Nervous system disorder—Betamethasone—psoriasis	4.05e-05	0.000175	CcSEcCtD
Saquinavir—Nervous system disorder—Dexamethasone—psoriasis	4.05e-05	0.000175	CcSEcCtD
Saquinavir—Agitation—Prednisone—psoriasis	4.05e-05	0.000175	CcSEcCtD
Saquinavir—Thrombocytopenia—Dexamethasone—psoriasis	4.05e-05	0.000175	CcSEcCtD
Saquinavir—Thrombocytopenia—Betamethasone—psoriasis	4.05e-05	0.000175	CcSEcCtD
Saquinavir—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	4.05e-05	0.00153	CbGpPWpGaD
Saquinavir—Hypersensitivity—Cyclosporine—psoriasis	4.01e-05	0.000173	CcSEcCtD
Saquinavir—Dyspepsia—Triamcinolone—psoriasis	4.01e-05	0.000173	CcSEcCtD
Saquinavir—Erythema multiforme—Methotrexate—psoriasis	4e-05	0.000173	CcSEcCtD
Saquinavir—Nausea—Mycophenolic acid—psoriasis	4e-05	0.000172	CcSEcCtD
Saquinavir—Hyperhidrosis—Dexamethasone—psoriasis	4e-05	0.000172	CcSEcCtD
Saquinavir—Hyperhidrosis—Betamethasone—psoriasis	4e-05	0.000172	CcSEcCtD
Saquinavir—Feeling abnormal—Hydrocortisone—psoriasis	3.99e-05	0.000172	CcSEcCtD
Saquinavir—Malaise—Prednisone—psoriasis	3.98e-05	0.000172	CcSEcCtD
Saquinavir—Vertigo—Prednisone—psoriasis	3.96e-05	0.000171	CcSEcCtD
Saquinavir—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	3.96e-05	0.0015	CbGpPWpGaD
Saquinavir—Eye disorder—Methotrexate—psoriasis	3.96e-05	0.000171	CcSEcCtD
Saquinavir—Gastrointestinal pain—Hydrocortisone—psoriasis	3.96e-05	0.000171	CcSEcCtD
Saquinavir—Syncope—Prednisone—psoriasis	3.96e-05	0.000171	CcSEcCtD
Saquinavir—Tinnitus—Methotrexate—psoriasis	3.95e-05	0.00017	CcSEcCtD
Saquinavir—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	3.94e-05	0.00149	CbGpPWpGaD
Saquinavir—Anorexia—Betamethasone—psoriasis	3.94e-05	0.00017	CcSEcCtD
Saquinavir—Anorexia—Dexamethasone—psoriasis	3.94e-05	0.00017	CcSEcCtD
Saquinavir—Urticaria—Prednisolone—psoriasis	3.94e-05	0.00017	CcSEcCtD
Saquinavir—Cardiac disorder—Methotrexate—psoriasis	3.93e-05	0.00017	CcSEcCtD
Saquinavir—Fatigue—Triamcinolone—psoriasis	3.93e-05	0.000169	CcSEcCtD
Saquinavir—ABCC1—Metabolism—NDUFA5—psoriasis	3.92e-05	0.00148	CbGpPWpGaD
Saquinavir—Hypersensitivity—Mycophenolate mofetil—psoriasis	3.91e-05	0.000169	CcSEcCtD
Saquinavir—Asthenia—Cyclosporine—psoriasis	3.91e-05	0.000168	CcSEcCtD
Saquinavir—Pain—Triamcinolone—psoriasis	3.9e-05	0.000168	CcSEcCtD
Saquinavir—ALB—SLC-mediated transmembrane transport—CP—psoriasis	3.89e-05	0.00147	CbGpPWpGaD
Saquinavir—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	3.88e-05	0.00146	CbGpPWpGaD
Saquinavir—Loss of consciousness—Prednisone—psoriasis	3.88e-05	0.000167	CcSEcCtD
Saquinavir—Hypotension—Dexamethasone—psoriasis	3.86e-05	0.000167	CcSEcCtD
Saquinavir—Hypotension—Betamethasone—psoriasis	3.86e-05	0.000167	CcSEcCtD
Saquinavir—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	3.86e-05	0.00146	CbGpPWpGaD
Saquinavir—Pruritus—Cyclosporine—psoriasis	3.85e-05	0.000166	CcSEcCtD
Saquinavir—Urticaria—Hydrocortisone—psoriasis	3.84e-05	0.000166	CcSEcCtD
Saquinavir—Angiopathy—Methotrexate—psoriasis	3.84e-05	0.000166	CcSEcCtD
Saquinavir—Immune system disorder—Methotrexate—psoriasis	3.83e-05	0.000165	CcSEcCtD
Saquinavir—Abdominal pain—Hydrocortisone—psoriasis	3.83e-05	0.000165	CcSEcCtD
Saquinavir—Body temperature increased—Hydrocortisone—psoriasis	3.83e-05	0.000165	CcSEcCtD
Saquinavir—Convulsion—Prednisone—psoriasis	3.82e-05	0.000165	CcSEcCtD
Saquinavir—Mediastinal disorder—Methotrexate—psoriasis	3.82e-05	0.000165	CcSEcCtD
Saquinavir—Asthenia—Mycophenolate mofetil—psoriasis	3.81e-05	0.000164	CcSEcCtD
Saquinavir—Hypertension—Prednisone—psoriasis	3.81e-05	0.000164	CcSEcCtD
Saquinavir—Chills—Methotrexate—psoriasis	3.8e-05	0.000164	CcSEcCtD
Saquinavir—ALB—Folate Metabolism—IFNG—psoriasis	3.8e-05	0.00143	CbGpPWpGaD
Saquinavir—Musculoskeletal discomfort—Betamethasone—psoriasis	3.77e-05	0.000162	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.77e-05	0.000162	CcSEcCtD
Saquinavir—Pruritus—Mycophenolate mofetil—psoriasis	3.76e-05	0.000162	CcSEcCtD
Saquinavir—Myalgia—Prednisone—psoriasis	3.76e-05	0.000162	CcSEcCtD
Saquinavir—Arthralgia—Prednisone—psoriasis	3.76e-05	0.000162	CcSEcCtD
Saquinavir—Feeling abnormal—Triamcinolone—psoriasis	3.76e-05	0.000162	CcSEcCtD
Saquinavir—Anxiety—Prednisone—psoriasis	3.74e-05	0.000161	CcSEcCtD
Saquinavir—Alopecia—Methotrexate—psoriasis	3.74e-05	0.000161	CcSEcCtD
Saquinavir—Insomnia—Dexamethasone—psoriasis	3.74e-05	0.000161	CcSEcCtD
Saquinavir—Insomnia—Betamethasone—psoriasis	3.74e-05	0.000161	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	3.73e-05	0.000161	CcSEcCtD
Saquinavir—Diarrhoea—Cyclosporine—psoriasis	3.73e-05	0.000161	CcSEcCtD
Saquinavir—SLCO1B1—Metabolism—NDUFA5—psoriasis	3.72e-05	0.0014	CbGpPWpGaD
Saquinavir—Paraesthesia—Dexamethasone—psoriasis	3.71e-05	0.00016	CcSEcCtD
Saquinavir—Paraesthesia—Betamethasone—psoriasis	3.71e-05	0.00016	CcSEcCtD
Saquinavir—Discomfort—Prednisone—psoriasis	3.71e-05	0.00016	CcSEcCtD
Saquinavir—Mental disorder—Methotrexate—psoriasis	3.71e-05	0.00016	CcSEcCtD
Saquinavir—SLCO1A2—Metabolism—CYP2S1—psoriasis	3.7e-05	0.0014	CbGpPWpGaD
Saquinavir—Malnutrition—Methotrexate—psoriasis	3.69e-05	0.000159	CcSEcCtD
Saquinavir—Erythema—Methotrexate—psoriasis	3.69e-05	0.000159	CcSEcCtD
Saquinavir—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	3.68e-05	0.00139	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.65e-05	0.00138	CbGpPWpGaD
Saquinavir—Hypersensitivity—Prednisolone—psoriasis	3.65e-05	0.000157	CcSEcCtD
Saquinavir—ABCC1—Transmembrane transport of small molecules—CP—psoriasis	3.64e-05	0.00137	CbGpPWpGaD
Saquinavir—Dyspepsia—Dexamethasone—psoriasis	3.64e-05	0.000157	CcSEcCtD
Saquinavir—Dyspepsia—Betamethasone—psoriasis	3.64e-05	0.000157	CcSEcCtD
Saquinavir—Diarrhoea—Mycophenolate mofetil—psoriasis	3.63e-05	0.000157	CcSEcCtD
Saquinavir—Urticaria—Triamcinolone—psoriasis	3.62e-05	0.000156	CcSEcCtD
Saquinavir—Dysgeusia—Methotrexate—psoriasis	3.61e-05	0.000156	CcSEcCtD
Saquinavir—Body temperature increased—Triamcinolone—psoriasis	3.6e-05	0.000155	CcSEcCtD
Saquinavir—Dizziness—Cyclosporine—psoriasis	3.6e-05	0.000155	CcSEcCtD
Saquinavir—Oedema—Prednisone—psoriasis	3.6e-05	0.000155	CcSEcCtD
Saquinavir—Decreased appetite—Dexamethasone—psoriasis	3.59e-05	0.000155	CcSEcCtD
Saquinavir—Decreased appetite—Betamethasone—psoriasis	3.59e-05	0.000155	CcSEcCtD
Saquinavir—Infection—Prednisone—psoriasis	3.58e-05	0.000154	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Betamethasone—psoriasis	3.57e-05	0.000154	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Dexamethasone—psoriasis	3.57e-05	0.000154	CcSEcCtD
Saquinavir—Back pain—Methotrexate—psoriasis	3.57e-05	0.000154	CcSEcCtD
Saquinavir—Hypersensitivity—Hydrocortisone—psoriasis	3.57e-05	0.000154	CcSEcCtD
Saquinavir—Fatigue—Betamethasone—psoriasis	3.56e-05	0.000154	CcSEcCtD
Saquinavir—Fatigue—Dexamethasone—psoriasis	3.56e-05	0.000154	CcSEcCtD
Saquinavir—Shock—Prednisone—psoriasis	3.54e-05	0.000153	CcSEcCtD
Saquinavir—Pain—Dexamethasone—psoriasis	3.54e-05	0.000152	CcSEcCtD
Saquinavir—Pain—Betamethasone—psoriasis	3.54e-05	0.000152	CcSEcCtD
Saquinavir—Nervous system disorder—Prednisone—psoriasis	3.53e-05	0.000152	CcSEcCtD
Saquinavir—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	3.51e-05	0.00133	CbGpPWpGaD
Saquinavir—Dizziness—Mycophenolate mofetil—psoriasis	3.51e-05	0.000151	CcSEcCtD
Saquinavir—Skin disorder—Prednisone—psoriasis	3.5e-05	0.000151	CcSEcCtD
Saquinavir—Hyperhidrosis—Prednisone—psoriasis	3.48e-05	0.00015	CcSEcCtD
Saquinavir—ABCC1—Transmembrane transport of small molecules—CARM1—psoriasis	3.47e-05	0.00131	CbGpPWpGaD
Saquinavir—Asthenia—Hydrocortisone—psoriasis	3.47e-05	0.00015	CcSEcCtD
Saquinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.47e-05	0.00131	CbGpPWpGaD
Saquinavir—Vomiting—Cyclosporine—psoriasis	3.46e-05	0.000149	CcSEcCtD
Saquinavir—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	3.46e-05	0.00131	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—NDUFA5—psoriasis	3.45e-05	0.0013	CbGpPWpGaD
Saquinavir—Rash—Cyclosporine—psoriasis	3.43e-05	0.000148	CcSEcCtD
Saquinavir—Anorexia—Prednisone—psoriasis	3.43e-05	0.000148	CcSEcCtD
Saquinavir—Dermatitis—Cyclosporine—psoriasis	3.43e-05	0.000148	CcSEcCtD
Saquinavir—Pruritus—Hydrocortisone—psoriasis	3.42e-05	0.000148	CcSEcCtD
Saquinavir—Ill-defined disorder—Methotrexate—psoriasis	3.42e-05	0.000148	CcSEcCtD
Saquinavir—CYP3A7—Metabolism—NDUFA5—psoriasis	3.42e-05	0.00129	CbGpPWpGaD
Saquinavir—Headache—Cyclosporine—psoriasis	3.41e-05	0.000147	CcSEcCtD
Saquinavir—Anaemia—Methotrexate—psoriasis	3.41e-05	0.000147	CcSEcCtD
Saquinavir—Feeling abnormal—Betamethasone—psoriasis	3.41e-05	0.000147	CcSEcCtD
Saquinavir—Feeling abnormal—Dexamethasone—psoriasis	3.41e-05	0.000147	CcSEcCtD
Saquinavir—Gastrointestinal pain—Dexamethasone—psoriasis	3.38e-05	0.000146	CcSEcCtD
Saquinavir—Gastrointestinal pain—Betamethasone—psoriasis	3.38e-05	0.000146	CcSEcCtD
Saquinavir—Vomiting—Mycophenolate mofetil—psoriasis	3.38e-05	0.000146	CcSEcCtD
Saquinavir—Hypersensitivity—Triamcinolone—psoriasis	3.36e-05	0.000145	CcSEcCtD
Saquinavir—Rash—Mycophenolate mofetil—psoriasis	3.35e-05	0.000144	CcSEcCtD
Saquinavir—Dermatitis—Mycophenolate mofetil—psoriasis	3.35e-05	0.000144	CcSEcCtD
Saquinavir—ABCC1—Metabolism—CYP2S1—psoriasis	3.33e-05	0.00126	CbGpPWpGaD
Saquinavir—Headache—Mycophenolate mofetil—psoriasis	3.33e-05	0.000143	CcSEcCtD
Saquinavir—Malaise—Methotrexate—psoriasis	3.33e-05	0.000143	CcSEcCtD
Saquinavir—Vertigo—Methotrexate—psoriasis	3.31e-05	0.000143	CcSEcCtD
Saquinavir—Diarrhoea—Hydrocortisone—psoriasis	3.31e-05	0.000143	CcSEcCtD
Saquinavir—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	3.3e-05	0.00125	CbGpPWpGaD
Saquinavir—Leukopenia—Methotrexate—psoriasis	3.3e-05	0.000142	CcSEcCtD
Saquinavir—Urticaria—Dexamethasone—psoriasis	3.28e-05	0.000142	CcSEcCtD
Saquinavir—Urticaria—Betamethasone—psoriasis	3.28e-05	0.000142	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Prednisone—psoriasis	3.28e-05	0.000141	CcSEcCtD
Saquinavir—Dizziness—Prednisolone—psoriasis	3.28e-05	0.000141	CcSEcCtD
Saquinavir—Asthenia—Triamcinolone—psoriasis	3.27e-05	0.000141	CcSEcCtD
Saquinavir—Abdominal pain—Dexamethasone—psoriasis	3.27e-05	0.000141	CcSEcCtD
Saquinavir—Body temperature increased—Dexamethasone—psoriasis	3.27e-05	0.000141	CcSEcCtD
Saquinavir—Body temperature increased—Betamethasone—psoriasis	3.27e-05	0.000141	CcSEcCtD
Saquinavir—Abdominal pain—Betamethasone—psoriasis	3.27e-05	0.000141	CcSEcCtD
Saquinavir—Insomnia—Prednisone—psoriasis	3.26e-05	0.00014	CcSEcCtD
Saquinavir—Nausea—Cyclosporine—psoriasis	3.23e-05	0.000139	CcSEcCtD
Saquinavir—Paraesthesia—Prednisone—psoriasis	3.23e-05	0.000139	CcSEcCtD
Saquinavir—Pruritus—Triamcinolone—psoriasis	3.22e-05	0.000139	CcSEcCtD
Saquinavir—Cough—Methotrexate—psoriasis	3.22e-05	0.000139	CcSEcCtD
Saquinavir—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	3.2e-05	0.00121	CbGpPWpGaD
Saquinavir—Dizziness—Hydrocortisone—psoriasis	3.2e-05	0.000138	CcSEcCtD
Saquinavir—Convulsion—Methotrexate—psoriasis	3.19e-05	0.000138	CcSEcCtD
Saquinavir—SLC22A1—Metabolism—NDUFA5—psoriasis	3.18e-05	0.0012	CbGpPWpGaD
Saquinavir—Dyspepsia—Prednisone—psoriasis	3.17e-05	0.000137	CcSEcCtD
Saquinavir—SLCO1B1—Metabolism—CYP2S1—psoriasis	3.17e-05	0.00119	CbGpPWpGaD
Saquinavir—ALB—Folate Metabolism—NFKB1—psoriasis	3.16e-05	0.00119	CbGpPWpGaD
Saquinavir—Nausea—Mycophenolate mofetil—psoriasis	3.16e-05	0.000136	CcSEcCtD
Saquinavir—Myalgia—Methotrexate—psoriasis	3.14e-05	0.000135	CcSEcCtD
Saquinavir—Chest pain—Methotrexate—psoriasis	3.14e-05	0.000135	CcSEcCtD
Saquinavir—Arthralgia—Methotrexate—psoriasis	3.14e-05	0.000135	CcSEcCtD
Saquinavir—Decreased appetite—Prednisone—psoriasis	3.13e-05	0.000135	CcSEcCtD
Saquinavir—Rash—Prednisolone—psoriasis	3.12e-05	0.000135	CcSEcCtD
Saquinavir—Dermatitis—Prednisolone—psoriasis	3.12e-05	0.000135	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.12e-05	0.000134	CcSEcCtD
Saquinavir—Fatigue—Prednisone—psoriasis	3.1e-05	0.000134	CcSEcCtD
Saquinavir—Headache—Prednisolone—psoriasis	3.1e-05	0.000134	CcSEcCtD
Saquinavir—Discomfort—Methotrexate—psoriasis	3.1e-05	0.000134	CcSEcCtD
Saquinavir—Constipation—Prednisone—psoriasis	3.08e-05	0.000133	CcSEcCtD
Saquinavir—Vomiting—Hydrocortisone—psoriasis	3.08e-05	0.000133	CcSEcCtD
Saquinavir—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	3.06e-05	0.00115	CbGpPWpGaD
Saquinavir—Rash—Hydrocortisone—psoriasis	3.05e-05	0.000132	CcSEcCtD
Saquinavir—Dermatitis—Hydrocortisone—psoriasis	3.05e-05	0.000131	CcSEcCtD
Saquinavir—Confusional state—Methotrexate—psoriasis	3.03e-05	0.000131	CcSEcCtD
Saquinavir—Headache—Hydrocortisone—psoriasis	3.03e-05	0.000131	CcSEcCtD
Saquinavir—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.02e-05	0.00114	CbGpPWpGaD
Saquinavir—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.02e-05	0.00114	CbGpPWpGaD
Saquinavir—Dizziness—Triamcinolone—psoriasis	3.01e-05	0.00013	CcSEcCtD
Saquinavir—Infection—Methotrexate—psoriasis	2.99e-05	0.000129	CcSEcCtD
Saquinavir—Feeling abnormal—Prednisone—psoriasis	2.97e-05	0.000128	CcSEcCtD
Saquinavir—Asthenia—Betamethasone—psoriasis	2.97e-05	0.000128	CcSEcCtD
Saquinavir—Asthenia—Dexamethasone—psoriasis	2.97e-05	0.000128	CcSEcCtD
Saquinavir—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	2.96e-05	0.00112	CbGpPWpGaD
Saquinavir—Nervous system disorder—Methotrexate—psoriasis	2.95e-05	0.000127	CcSEcCtD
Saquinavir—Thrombocytopenia—Methotrexate—psoriasis	2.95e-05	0.000127	CcSEcCtD
Saquinavir—Gastrointestinal pain—Prednisone—psoriasis	2.94e-05	0.000127	CcSEcCtD
Saquinavir—Nausea—Prednisolone—psoriasis	2.94e-05	0.000127	CcSEcCtD
Saquinavir—ABCG2—Metabolism—CYP2S1—psoriasis	2.93e-05	0.00111	CbGpPWpGaD
Saquinavir—Pruritus—Dexamethasone—psoriasis	2.93e-05	0.000126	CcSEcCtD
Saquinavir—Pruritus—Betamethasone—psoriasis	2.93e-05	0.000126	CcSEcCtD
Saquinavir—Skin disorder—Methotrexate—psoriasis	2.92e-05	0.000126	CcSEcCtD
Saquinavir—Hyperhidrosis—Methotrexate—psoriasis	2.91e-05	0.000125	CcSEcCtD
Saquinavir—CYP3A7—Metabolism—CYP2S1—psoriasis	2.91e-05	0.0011	CbGpPWpGaD
Saquinavir—Vomiting—Triamcinolone—psoriasis	2.9e-05	0.000125	CcSEcCtD
Saquinavir—ABCB1—Allograft Rejection—IFNG—psoriasis	2.88e-05	0.00109	CbGpPWpGaD
Saquinavir—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.87e-05	0.00108	CbGpPWpGaD
Saquinavir—Nausea—Hydrocortisone—psoriasis	2.87e-05	0.000124	CcSEcCtD
Saquinavir—Rash—Triamcinolone—psoriasis	2.87e-05	0.000124	CcSEcCtD
Saquinavir—Dermatitis—Triamcinolone—psoriasis	2.87e-05	0.000124	CcSEcCtD
Saquinavir—Anorexia—Methotrexate—psoriasis	2.87e-05	0.000124	CcSEcCtD
Saquinavir—Urticaria—Prednisone—psoriasis	2.86e-05	0.000123	CcSEcCtD
Saquinavir—Headache—Triamcinolone—psoriasis	2.85e-05	0.000123	CcSEcCtD
Saquinavir—Abdominal pain—Prednisone—psoriasis	2.85e-05	0.000123	CcSEcCtD
Saquinavir—Body temperature increased—Prednisone—psoriasis	2.85e-05	0.000123	CcSEcCtD
Saquinavir—Diarrhoea—Dexamethasone—psoriasis	2.83e-05	0.000122	CcSEcCtD
Saquinavir—Diarrhoea—Betamethasone—psoriasis	2.83e-05	0.000122	CcSEcCtD
Saquinavir—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	2.82e-05	0.00106	CbGpPWpGaD
Saquinavir—Hypotension—Methotrexate—psoriasis	2.81e-05	0.000121	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Methotrexate—psoriasis	2.74e-05	0.000118	CcSEcCtD
Saquinavir—Dizziness—Betamethasone—psoriasis	2.73e-05	0.000118	CcSEcCtD
Saquinavir—Dizziness—Dexamethasone—psoriasis	2.73e-05	0.000118	CcSEcCtD
Saquinavir—Insomnia—Methotrexate—psoriasis	2.72e-05	0.000117	CcSEcCtD
Saquinavir—Nausea—Triamcinolone—psoriasis	2.71e-05	0.000117	CcSEcCtD
Saquinavir—SLC22A1—Metabolism—CYP2S1—psoriasis	2.7e-05	0.00102	CbGpPWpGaD
Saquinavir—Paraesthesia—Methotrexate—psoriasis	2.7e-05	0.000117	CcSEcCtD
Saquinavir—Dyspnoea—Methotrexate—psoriasis	2.68e-05	0.000116	CcSEcCtD
Saquinavir—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.68e-05	0.00101	CbGpPWpGaD
Saquinavir—Somnolence—Methotrexate—psoriasis	2.68e-05	0.000115	CcSEcCtD
Saquinavir—Hypersensitivity—Prednisone—psoriasis	2.65e-05	0.000114	CcSEcCtD
Saquinavir—Dyspepsia—Methotrexate—psoriasis	2.65e-05	0.000114	CcSEcCtD
Saquinavir—CYP11A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.65e-05	0.000999	CbGpPWpGaD
Saquinavir—Vomiting—Dexamethasone—psoriasis	2.63e-05	0.000113	CcSEcCtD
Saquinavir—Vomiting—Betamethasone—psoriasis	2.63e-05	0.000113	CcSEcCtD
Saquinavir—Decreased appetite—Methotrexate—psoriasis	2.62e-05	0.000113	CcSEcCtD
Saquinavir—Rash—Dexamethasone—psoriasis	2.61e-05	0.000112	CcSEcCtD
Saquinavir—Rash—Betamethasone—psoriasis	2.61e-05	0.000112	CcSEcCtD
Saquinavir—Dermatitis—Dexamethasone—psoriasis	2.6e-05	0.000112	CcSEcCtD
Saquinavir—Dermatitis—Betamethasone—psoriasis	2.6e-05	0.000112	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Methotrexate—psoriasis	2.6e-05	0.000112	CcSEcCtD
Saquinavir—Fatigue—Methotrexate—psoriasis	2.59e-05	0.000112	CcSEcCtD
Saquinavir—Headache—Betamethasone—psoriasis	2.59e-05	0.000112	CcSEcCtD
Saquinavir—Headache—Dexamethasone—psoriasis	2.59e-05	0.000112	CcSEcCtD
Saquinavir—Asthenia—Prednisone—psoriasis	2.58e-05	0.000111	CcSEcCtD
Saquinavir—Pain—Methotrexate—psoriasis	2.57e-05	0.000111	CcSEcCtD
Saquinavir—Pruritus—Prednisone—psoriasis	2.55e-05	0.00011	CcSEcCtD
Saquinavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.51e-05	0.000948	CbGpPWpGaD
Saquinavir—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	2.51e-05	0.000947	CbGpPWpGaD
Saquinavir—Feeling abnormal—Methotrexate—psoriasis	2.48e-05	0.000107	CcSEcCtD
Saquinavir—CYP3A5—Metabolism—NDUFA5—psoriasis	2.47e-05	0.000932	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—CARM1—psoriasis	2.47e-05	0.000931	CbGpPWpGaD
Saquinavir—Diarrhoea—Prednisone—psoriasis	2.46e-05	0.000106	CcSEcCtD
Saquinavir—Gastrointestinal pain—Methotrexate—psoriasis	2.46e-05	0.000106	CcSEcCtD
Saquinavir—ALB—Platelet degranulation—VEGFA—psoriasis	2.46e-05	0.000927	CbGpPWpGaD
Saquinavir—ALB—Folate Metabolism—TNF—psoriasis	2.46e-05	0.000927	CbGpPWpGaD
Saquinavir—Nausea—Dexamethasone—psoriasis	2.46e-05	0.000106	CcSEcCtD
Saquinavir—Nausea—Betamethasone—psoriasis	2.46e-05	0.000106	CcSEcCtD
Saquinavir—ALB—Vitamin B12 Metabolism—IL6—psoriasis	2.44e-05	0.000919	CbGpPWpGaD
Saquinavir—Urticaria—Methotrexate—psoriasis	2.39e-05	0.000103	CcSEcCtD
Saquinavir—Dizziness—Prednisone—psoriasis	2.38e-05	0.000103	CcSEcCtD
Saquinavir—Abdominal pain—Methotrexate—psoriasis	2.38e-05	0.000103	CcSEcCtD
Saquinavir—Body temperature increased—Methotrexate—psoriasis	2.38e-05	0.000103	CcSEcCtD
Saquinavir—ALB—Hemostasis—ITGAL—psoriasis	2.36e-05	0.000892	CbGpPWpGaD
Saquinavir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.34e-05	0.000883	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.31e-05	0.00087	CbGpPWpGaD
Saquinavir—Vomiting—Prednisone—psoriasis	2.29e-05	9.87e-05	CcSEcCtD
Saquinavir—Rash—Prednisone—psoriasis	2.27e-05	9.79e-05	CcSEcCtD
Saquinavir—Dermatitis—Prednisone—psoriasis	2.27e-05	9.78e-05	CcSEcCtD
Saquinavir—Headache—Prednisone—psoriasis	2.26e-05	9.73e-05	CcSEcCtD
Saquinavir—Hypersensitivity—Methotrexate—psoriasis	2.22e-05	9.56e-05	CcSEcCtD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.21e-05	0.000832	CbGpPWpGaD
Saquinavir—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.18e-05	0.000821	CbGpPWpGaD
Saquinavir—ALB—Folate Metabolism—TP53—psoriasis	2.17e-05	0.000817	CbGpPWpGaD
Saquinavir—Asthenia—Methotrexate—psoriasis	2.16e-05	9.31e-05	CcSEcCtD
Saquinavir—CYP2C8—Metabolism—NDUFA5—psoriasis	2.14e-05	0.000807	CbGpPWpGaD
Saquinavir—Nausea—Prednisone—psoriasis	2.14e-05	9.22e-05	CcSEcCtD
Saquinavir—Pruritus—Methotrexate—psoriasis	2.13e-05	9.18e-05	CcSEcCtD
Saquinavir—ALB—Metabolism—NDUFA5—psoriasis	2.13e-05	0.000803	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—CYP2S1—psoriasis	2.1e-05	0.000792	CbGpPWpGaD
Saquinavir—Diarrhoea—Methotrexate—psoriasis	2.06e-05	8.88e-05	CcSEcCtD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.99e-05	0.000753	CbGpPWpGaD
Saquinavir—Dizziness—Methotrexate—psoriasis	1.99e-05	8.58e-05	CcSEcCtD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.98e-05	0.000748	CbGpPWpGaD
Saquinavir—ALB—Folate Metabolism—IL6—psoriasis	1.98e-05	0.000748	CbGpPWpGaD
Saquinavir—ALB—Transmembrane transport of small molecules—CP—psoriasis	1.98e-05	0.000746	CbGpPWpGaD
Saquinavir—ALB—Selenium Micronutrient Network—TNF—psoriasis	1.95e-05	0.000736	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.94e-05	0.000732	CbGpPWpGaD
Saquinavir—Vomiting—Methotrexate—psoriasis	1.91e-05	8.25e-05	CcSEcCtD
Saquinavir—CYP2C19—Metabolism—NDUFA5—psoriasis	1.91e-05	0.000721	CbGpPWpGaD
Saquinavir—Rash—Methotrexate—psoriasis	1.9e-05	8.18e-05	CcSEcCtD
Saquinavir—Dermatitis—Methotrexate—psoriasis	1.9e-05	8.17e-05	CcSEcCtD
Saquinavir—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	1.89e-05	0.000712	CbGpPWpGaD
Saquinavir—Headache—Methotrexate—psoriasis	1.89e-05	8.13e-05	CcSEcCtD
Saquinavir—ABCB1—Allograft Rejection—TNF—psoriasis	1.86e-05	0.000703	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—NDUFA5—psoriasis	1.86e-05	0.000703	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.85e-05	0.000699	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—CYP2S1—psoriasis	1.82e-05	0.000686	CbGpPWpGaD
Saquinavir—ALB—Metabolism—CYP2S1—psoriasis	1.81e-05	0.000682	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—CARM1—psoriasis	1.81e-05	0.000682	CbGpPWpGaD
Saquinavir—Nausea—Methotrexate—psoriasis	1.79e-05	7.71e-05	CcSEcCtD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.78e-05	0.000672	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—NDUFA5—psoriasis	1.76e-05	0.000663	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.75e-05	0.000659	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—NDUFA5—psoriasis	1.74e-05	0.000657	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.73e-05	0.000654	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.69e-05	0.000638	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.66e-05	0.000626	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.65e-05	0.000623	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—CARM1—psoriasis	1.63e-05	0.000614	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—CYP2S1—psoriasis	1.62e-05	0.000613	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.62e-05	0.000613	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—CYP2S1—psoriasis	1.58e-05	0.000598	CbGpPWpGaD
Saquinavir—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.57e-05	0.000594	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—CARM1—psoriasis	1.55e-05	0.000583	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.52e-05	0.000574	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—CAT—psoriasis	1.52e-05	0.000572	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—CYP2S1—psoriasis	1.49e-05	0.000563	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CYP2S1—psoriasis	1.48e-05	0.000559	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.44e-05	0.000545	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—CARM1—psoriasis	1.43e-05	0.00054	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—CARM1—psoriasis	1.42e-05	0.000535	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—CARM1—psoriasis	1.32e-05	0.000498	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.23e-05	0.000464	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.18e-05	0.000446	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—APOE—psoriasis	1.18e-05	0.000445	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—NDUFA5—psoriasis	1.15e-05	0.000433	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—CAT—psoriasis	1.11e-05	0.00042	CbGpPWpGaD
Saquinavir—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.09e-05	0.000411	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.07e-05	0.000405	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—PPARG—psoriasis	1.03e-05	0.000387	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—CARM1—psoriasis	1.03e-05	0.000387	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—CAT—psoriasis	1e-05	0.000378	CbGpPWpGaD
Saquinavir—ABCC1—Disease—HLA-A—psoriasis	9.94e-06	0.000375	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CYP2S1—psoriasis	9.76e-06	0.000368	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—NOS2—psoriasis	9.7e-06	0.000366	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.53e-06	0.00036	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—CAT—psoriasis	9.51e-06	0.000359	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.48e-06	0.000358	CbGpPWpGaD
Saquinavir—ABCC1—Disease—APOE—psoriasis	9.28e-06	0.00035	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	9.2e-06	0.000347	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—CARM1—psoriasis	8.88e-06	0.000335	CbGpPWpGaD
Saquinavir—ALB—Metabolism—CARM1—psoriasis	8.83e-06	0.000333	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—CAT—psoriasis	8.8e-06	0.000332	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—CAT—psoriasis	8.73e-06	0.000329	CbGpPWpGaD
Saquinavir—ABCC1—Disease—NOS2—psoriasis	8.65e-06	0.000326	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—APOE—psoriasis	8.64e-06	0.000326	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.51e-06	0.000321	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.3e-06	0.000313	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.26e-06	0.000312	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—CAT—psoriasis	8.12e-06	0.000306	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.11e-06	0.000306	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—CARM1—psoriasis	7.93e-06	0.000299	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—APOE—psoriasis	7.77e-06	0.000293	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.76e-06	0.000293	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—CARM1—psoriasis	7.74e-06	0.000292	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PPARG—psoriasis	7.53e-06	0.000284	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.41e-06	0.00028	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—APOE—psoriasis	7.39e-06	0.000279	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—CARM1—psoriasis	7.29e-06	0.000275	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CARM1—psoriasis	7.23e-06	0.000273	CbGpPWpGaD
Saquinavir—ABCC1—Disease—TYK2—psoriasis	7.09e-06	0.000267	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—APOE—psoriasis	6.84e-06	0.000258	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—APOE—psoriasis	6.78e-06	0.000256	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PPARG—psoriasis	6.77e-06	0.000256	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.76e-06	0.000255	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PPARG—psoriasis	6.44e-06	0.000243	CbGpPWpGaD
Saquinavir—ABCC1—Disease—CD4—psoriasis	6.41e-06	0.000242	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—APOE—psoriasis	6.31e-06	0.000238	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—CAT—psoriasis	6.31e-06	0.000238	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PPARG—psoriasis	5.96e-06	0.000225	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PPARG—psoriasis	5.91e-06	0.000223	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—VEGFA—psoriasis	5.62e-06	0.000212	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PPARG—psoriasis	5.5e-06	0.000207	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—CAT—psoriasis	5.46e-06	0.000206	CbGpPWpGaD
Saquinavir—ALB—Metabolism—CAT—psoriasis	5.43e-06	0.000205	CbGpPWpGaD
Saquinavir—ABCC1—Disease—STAT3—psoriasis	4.96e-06	0.000187	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—APOE—psoriasis	4.9e-06	0.000185	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—CAT—psoriasis	4.88e-06	0.000184	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CARM1—psoriasis	4.77e-06	0.00018	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—CAT—psoriasis	4.76e-06	0.00018	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—CAT—psoriasis	4.49e-06	0.000169	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CAT—psoriasis	4.45e-06	0.000168	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PPARG—psoriasis	4.27e-06	0.000161	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—TP53—psoriasis	4.25e-06	0.00016	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—APOE—psoriasis	4.25e-06	0.00016	CbGpPWpGaD
Saquinavir—ALB—Metabolism—APOE—psoriasis	4.22e-06	0.000159	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—APOE—psoriasis	3.79e-06	0.000143	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—APOE—psoriasis	3.7e-06	0.00014	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PPARG—psoriasis	3.7e-06	0.00014	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PPARG—psoriasis	3.68e-06	0.000139	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—APOE—psoriasis	3.49e-06	0.000132	CbGpPWpGaD
Saquinavir—ABCC1—Disease—IL6—psoriasis	3.47e-06	0.000131	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—APOE—psoriasis	3.46e-06	0.00013	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PPARG—psoriasis	3.3e-06	0.000125	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PPARG—psoriasis	3.22e-06	0.000122	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PPARG—psoriasis	3.04e-06	0.000115	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PPARG—psoriasis	3.01e-06	0.000114	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CAT—psoriasis	2.93e-06	0.000111	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—APOE—psoriasis	2.28e-06	8.6e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PPARG—psoriasis	1.98e-06	7.49e-05	CbGpPWpGaD
